Australia's Acrux eyes best day on US product launch

Acrux

03/04/2024 01:50

** Shares of Acrux  ACR.AX  rise as much as 110.6% to
A$0.099, on track for their best day, if gains hold
    ** Stock hits highest level since March 3, 2022 
    ** The specialty pharmaceutical co announces launch of a
Dapsone 5%, Gel product in the United States
    ** Says Dapsone 5%, Gel is a prescription medicine used on
skin to treat acne
    ** Says annual market sales for Dapsone 5%, Gel products for
the 12 months ending Oct 2023 exceeded $15 mln
    ** About 20.5 mln shares change hands, compared with 30-day
average trading volume of 183,086 shares 
    ** Stock up 6.8% YTD, as of last close 
   

 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))